Showing results (301-310 of 454) with videos related to
Sort By:
Pageof 46
Journal of Biomedical Nanotechnology|April 16, 2014
Carbon nanofibers and carbon nanotubes sensitize prostate and bladder cancer cells to platinum-based chemotherapeuticsJessica Ringel, Kati Erdmann, Silke Hampel, et al.Plos One|October 4, 2016
High Coverage and Utilization of Fortified Take-Home Rations among Children 6-35 Months of Age Provided through the Integrated Child Development Services Program: Findings from a Cross-Sectional Survey in Telangana, IndiaMagali Leyvraz, James P Wirth, Bradley A Woodruff, et al.Digestive Diseases and Sciences|April 1, 1995
Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's diseaseC Gasché, W Reinisch, H Vogelsang, et al.Plos One|July 16, 2014
Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinomaMarieta I Toma, Kati Erdmann, Michael Diezel, et al.Scandinavian Journal of Urology and Nephrology|November 24, 2005
Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.The Journal of Urology|June 11, 2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause, Yvonne Förster, Kai Kraemer, et al.Plos One|August 24, 2018
Implications of the Ebola virus disease outbreak in Guinea: Qualitative findings to inform future health and nutrition-related responsesStephen R Kodish, Fabian Rohner, Jean-Max Beauliere, et al.European Journal of Cancer Care|December 21, 2018
Online support groups offer low-threshold backing for family and friends of patients with prostate cancerAndreas Ihrig, Theresa Renner, Tanja Muck, et al.Journal of Thrombosis and Haemostasis : JTH|January 16, 2009
Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgeryJ Beyer, S Wessela, O W Hakenberg, et al.Plos One|October 3, 2013
Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinomaJuana Dornbusch, Aristeidis Zacharis, Matthias Meinhardt, et al.Pageof 46